Discontinue enoxaparin (Lovenox) 12-24 hours before tooth extraction
For most patients undergoing tooth extraction, enoxaparin should be stopped 12-24 hours before the procedure, with the last dose given at half the total daily dose. This recommendation is based on established perioperative anticoagulation guidelines for procedures with bleeding risk 1, 2.
Timing Based on Bleeding Risk
The specific timing depends on the bleeding risk assessment of the tooth extraction:
Low Bleeding Risk (Simple Extractions)
- Stop enoxaparin 12 hours before the procedure 1, 2
- This applies to simple single-tooth extractions or procedures where local hemostatic measures are readily achievable
- The last dose should be given at half the total daily dose 2
High Bleeding Risk (Complex Extractions)
- Stop enoxaparin 24 hours before the procedure 1, 2
- This applies to multiple extractions, surgical extractions, or patients with additional bleeding risk factors
- Again, the last dose should be at half the total daily dose 2
Key Clinical Considerations
Renal function matters significantly. While the 12-24 hour window applies to patients with normal to moderate renal function, those with severe renal impairment (creatinine clearance <30 mL/min) may require longer interruption periods due to prolonged drug elimination 2, 3.
No bridging therapy is needed. Unlike warfarin management, enoxaparin's predictable pharmacokinetics eliminate the need for bridging with unfractionated heparin 2, 4. The evidence shows that bridging actually increases bleeding risk without reducing thrombotic events 4.
Local hemostatic measures are typically sufficient for dental extractions in anticoagulated patients 5. The use of tranexamic acid mouthwash, gelatin sponges, or sutures can effectively manage bleeding without requiring prolonged anticoagulation interruption.
Resumption After Extraction
- Resume enoxaparin 24 hours after low-risk extractions 2, 6
- Resume enoxaparin 48-72 hours after high-risk or complicated extractions 2, 6
- Resume at the patient's full therapeutic dose once adequate hemostasis is established 2
Important Caveats
Consider the thrombotic risk. For patients at very high risk for thromboembolism (recent VTE within 3 months, mechanical heart valve, active cancer with VTE), the decision to interrupt anticoagulation requires careful risk-benefit assessment 2. In some cases, continuing anticoagulation with enhanced local hemostatic measures may be safer than interruption.
The evidence for dental procedures specifically is limited. Most guideline recommendations extrapolate from data on surgical procedures like CABG 1. However, dental extractions generally carry lower bleeding risk than major surgery, and some evidence suggests that continuing anticoagulation may be safe for simple extractions 7, 8.
Avoid unnecessary interruption. Research shows that LMWH bridging for dental extractions is often used inappropriately and adds substantial cost without clear benefit 7. For simple single-tooth extractions in patients on therapeutic anticoagulation, continuing therapy with local hemostatic measures may be a reasonable alternative to interruption 8.